ALK-Abello alk.net

ALK delivers a research-driven global pharmaceutical company focusing on allergy treatment, prevention and diagnosis. ALK develops pharmaceutical products that target the actual cause of allergy.

ALK delivers a research-driven global pharmaceutical company focusing on allergy treatment, prevention and diagnosis. ALK develops pharmaceutical products that target the actual cause of allergy.

See All Exits Recent Exits

Phone: +45 4574 7576

Fax:

Boge Alle 6-8

 Horsholm, 2970
 Denmark

ALK-Abello - Investments & Acquisitions

Show Real Data ALK-Abello Investments
See all Recent Investments
Date Company Round Amount Co-investors
2016-12-27Crystal LaboratoryAcquired
2016-12-27Allergy LaboratoriesAcquired
2014-10-30SBT AquaGrant$0.32MDanish Eco-Innovation Program, Righospitalet, and Royal Unibrew
2014-02-12Bio-Medical ServicesAcquired
2011-01-05DBV TechnologiesSeries C$25.5MAlto Invest, InnoBio, Lundbeckfond Ventures, Shire, and Sofinnova Partners
See all 5 investments